Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
thioredoxin reductase | 3 | 0 | 0 | 3 |
GLS protein | 4 | 0 | 0 | 4 |
regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 5 | 0 | 0 | 5 |
estrogen nuclear receptor alpha | 7 | 0 | 0 | 7 |
NPYLR7B | 0 | 0 | 2 | 2 |
arylsulfatase A | 2 | 0 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 6 |
Bile salt export pump | 0 | 6 | 0 | 6 |
Beta-2 adrenergic receptor | 0 | 2 | 2 | 4 |
Beta-1 adrenergic receptor | 0 | 0 | 2 | 2 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Delta-type opioid receptor | 0 | 2 | 1 | 3 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 0 | 1 | 3 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 2 | 3 |
Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
AR protein | 6 | 0 | 0 | 6 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 2 | 0 | 3 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 0 | 1 | 1 |
Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 1 | 2 |
GLI family zinc finger 3 | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
retinoid X nuclear receptor alpha | 3 | 0 | 0 | 3 |
pregnane X nuclear receptor | 5 | 0 | 0 | 5 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 1 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
Luciferase | 2 | 0 | 0 | 2 |
TDP1 protein | 4 | 0 | 0 | 4 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 1 | 3 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 1 | 3 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
RAR-related orphan receptor gamma | 3 | 0 | 0 | 3 |
progesterone receptor | 3 | 0 | 0 | 3 |
retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
Interferon beta | 2 | 0 | 0 | 2 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Glucocorticoid receptor | 0 | 2 | 1 | 8 |
Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Androgen receptor | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 1 | 0 | 0 | 1 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
USP1 protein, partial | 3 | 0 | 0 | 3 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
Histone H2A.x | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 1 | 1 | 4 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 1 | 1 | 4 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 1 | 1 | 4 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 0 | 1 | 1 |
GABA theta subunit | 2 | 1 | 1 | 4 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 1 | 1 | 4 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
Thrombopoietin | 1 | 0 | 0 | 1 |
Smad3 | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
67.9K protein | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 1 | 0 | 0 | 1 |
LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 1 |
IDH1 | 2 | 0 | 0 | 2 |
beta-2 adrenergic receptor | 1 | 0 | 1 | 2 |
hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
glucokinase regulatory protein | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 2 | 0 | 0 | 2 |
geminin | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
Phosphodiesterase | 0 | 2 | 0 | 2 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
Renin | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 2 | 2 | 5 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Adenosine receptor A1 | 0 | 2 | 1 | 5 |
Adenosine receptor A2a | 0 | 1 | 0 | 3 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 0 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 0 | 1 | 1 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |